Lonza Group Revenue 2024

Lonza Group Revenue

6.79 B CHF

Lonza Group Dividend yield

0.33 %

Ticker

LONN.SW

ISIN

CH0013841017

WKN

928619

In 2024, Lonza Group's sales reached 6.79 B CHF, a 1.1% difference from the 6.72 B CHF sales recorded in the previous year.

The Lonza Group Revenue history

YEARREVENUE (undefined CHF)GROSS MARGIN (%)
2029e11.4321,05
2028e10.323,36
2027e9.3725,68
2026e8.6727,76
2025e7.7331,15
2024e6.7935,43
20236.7235,82
20226.2239,18
20215.4139,01
20204.5141,33
20194.2142,26
20185.5438,61
20174.5538,50
20164.1333,91
20153.828,90
20143.6429,51
20133.5823,05
20123.9325,61
20112.6926,00
20102.6826,53
20092.6920,26
20082.9428,57
20072.8728,22
20062.2924,68
20052.5222,25
20042.1821,49

Lonza Group Aktienanalyse

What does Lonza Group do?

The Lonza Group AG is a global company based in Basel, Switzerland. It was founded in 1897 and has since had a long history of operational excellence and innovation. Lonza is a leading provider of customized chemical and biotechnological solutions and services for customers in the health, agrochemical, life science, and other sectors. Lonza's business model is based on providing customized, customer-oriented solutions for complex chemical and biological challenges. The company focuses on three main divisions: Pharma & Biotech, Consumer Health, and Specialty Ingredients. Within these divisions, Lonza offers a variety of products, services, and solutions tailored to meet the specific needs of its customers. In the Pharma & Biotech division, Lonza offers a wide range of products and services for the pharmaceutical and biotechnology industries. The company is a global leader in active ingredients for the pharmaceutical industry and also provides custom process development and manufacturing services for biopharmaceuticals and small molecules. In the Consumer Health division, Lonza develops and produces a variety of dietary supplements, cosmetic products, and household products for its customers. The company is a recognized expert in the formulation and production of high-quality dietary supplements and has also established a strong position in the production of natural cosmetic products in recent years. Lonza's Specialty Ingredients division offers a wide range of chemical and biotechnological products and services for the life science and specialty chemical industries. This includes products and services such as microbial control, material protection, custom development services, and others. Lonza is a leading manufacturer and supplier of dietary supplements, pharmaceutical active ingredients, agrochemicals, cosmetic ingredients, and other chemical and biotechnological products. The company has extensive expertise in process development and optimization, as well as in the manufacturing of products for various industries. One of Lonza's key products is the active ingredient Mipomersen, which is used in the treatment of familial hypercholesterolemia. Lonza is also a major provider of dietary supplements, particularly vitamins, minerals, omega-3 fatty acids, and other nutrients that can promote and support human health. Another important product of Lonza is the biosimilar component recombinant human insulin, which is used in the treatment of diabetes. Overall, Lonza is an innovative and leading company in the field of chemistry and biotechnology. With a strong focus on customer-oriented solutions and a broad portfolio of products and services, the company is well positioned to meet the growing demand for chemical and biological solutions in various industries. Lonza Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Lonza Group's Sales Figures

The sales figures of Lonza Group originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Lonza Group’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Lonza Group's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Lonza Group’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Lonza Group Stock

How much revenue did Lonza Group generate this year?

Lonza Group has achieved a revenue of 6.79 B CHF this year.

How much was the turnover of the company Lonza Group compared to the previous year?

The revenue of Lonza Group has increased by 1.1% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Lonza Group?

The revenue of Lonza Group is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Lonza Group measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Lonza Group so important for investors?

The revenue of Lonza Group is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Lonza Group pay?

Over the past 12 months, Lonza Group paid a dividend of 1.75 CHF . This corresponds to a dividend yield of about 0.33 %. For the coming 12 months, Lonza Group is expected to pay a dividend of 1.93 CHF.

What is the dividend yield of Lonza Group?

The current dividend yield of Lonza Group is 0.33 %.

When does Lonza Group pay dividends?

Lonza Group pays a quarterly dividend. This is distributed in the months of June, June, June, June.

How secure is the dividend of Lonza Group?

Lonza Group paid dividends every year for the past 0 years.

What is the dividend of Lonza Group?

For the upcoming 12 months, dividends amounting to 1.93 CHF are expected. This corresponds to a dividend yield of 0.37 %.

In which sector is Lonza Group located?

Lonza Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Lonza Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Lonza Group from 5/15/2024 amounting to 2 CHF, you needed to have the stock in your portfolio before the ex-date on 5/13/2024.

When did Lonza Group pay the last dividend?

The last dividend was paid out on 5/15/2024.

What was the dividend of Lonza Group in the year 2023?

In the year 2023, Lonza Group distributed 1.5 CHF as dividends.

In which currency does Lonza Group pay out the dividend?

The dividends of Lonza Group are distributed in CHF.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Lonza Group

Our stock analysis for Lonza Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Lonza Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.